Second positive Phase III trial of AstraZeneca and Daiichi Sankyo’s Enhertu in HER2-positive early breast cancer reinforces its potential to become a foundational treatment option in curative-intent setting
Approval based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death for the Imfinzi regimen vs. neoadjuvant chemotherapy alone
EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults
Imfinzi reduced the risk of distant metastases and death from bladder cancer vs. neoadjuvant chemotherapy alone
First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery
The medical team led by Dr. Babu Ezhumalai implanted the dual-chamber leadless pacemaker through a non-surgical procedure successfully
The glucometer connects to one’s smartphone and provides actionable diagnostic information
New Centre of Excellence brings advanced robotic platforms and multidisciplinary expertise under one roof to expand access to precision-led minimally invasive surgery
Subscribe To Our Newsletter & Stay Updated
